Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Human Immunodeficiency Virus (HIV) Diagnosis Market In The Coming Years?

In recent times, there has been a swift expansion in the market size of human immunodeficiency virus (HIV) diagnosis. From $4.2 billion in 2024, the expected growth is projected to reach $4.67 billion in 2025 with a compound annual growth rate (CAGR) of 11.2%. The historical growth can be linked to the augmentation of voluntary counseling and testing, advances in HIV antibody tests, the advent of the HIV/AIDS epidemic, and initiatives led by community and peers.

Predictions indicate there will be a robust expansion in the market size for human immunodeficiency virus (hiv) diagnosis in the forthcoming years. It’s projected to escalate to $6.88 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. The upswing during the projection period can be credited to various factors such as public health campaigns, focus on equity and inclusivity, regular testing in healthcare settings, community-driven and peer-driven models, as well as accessibility to self-testing. Expectations for the forecasted period also involve progress in testing technologies, stress on strategic targeted testing, community-oriented testing, fostering equity and inclusivity, and setting policy and funding agendas.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

Which Growth Drivers Are Shaping The Human Immunodeficiency Virus (HIV) Diagnosis Market Outlook?

The upward trend in blood donations is expected to stimulate the expansion of the HIV diagnosis market. Blood donation, which is characterized by the voluntary provision of blood through phlebotomy, where a needle is used to extract blood from a vein, is experiencing a rise. Enhanced medical technology, greater community involvement, and more effective strategies to recruit and retain donors are contributing to this rise in blood donations. As more individuals donate blood, a greater spectrum of samples becomes available for HIV testing. This larger supply of blood samples creates opportunities for broader screening for HIV antibodies or antigens, heightening the precision and dependability of HIV diagnosis. For example, the number of novel blood donors at NHS Blood and Transplant, a government agency based in the UK, rose from 119,016 in 2022-2023 to 119,371 in 2023-2024. Consequently, the escalating trend in blood donations is fuelling the expansion of the HIV diagnosis market.

What Is The Segment Breakdown Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?

The human immunodeficiency virus (hiv) diagnosismarket covered in this report is segmented –

1) By Product: Consumables; Instruments; Software And Services

2) By Mode: Self-Test; Lab-Based

3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions

Subsegments:

1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment

2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments

3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools

4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing

How Are Global Trends Impacting The Development Of The Human Immunodeficiency Virus (HIV) Diagnosis Market?

Prominent entities in the HIV diagnosis market are concentrating on the innovation of chip-based real-time PCR HIV testing methods to enhance precision, minimize time lag and boost accessibility. These testing solutions use microfluidic chips or compact integrated circuits to carry out real-time polymerase chain reaction (PCR) tests needed to identify HIV. To cite an example, in August 2022, Molbio Diagnostics, a company based in India specializing in molecular diagnostics, released the Truenat HIV-1 test, a chip-based real-time PCR test designed for the quantitative identification and diagnoses of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma samples. The main objective of this test is to assist in monitoring the viral load of HIV-1 in infected patients. Including features of high primer sensitivity and specificity, the test uses a minimal sample volume of 6 mcL and comprises of an intelligent chip equipped with lot-specific data to quantify results. Furthermore, the test incorporates a chip re-use lock and a reaction port designed to resist contamination and evaporation.

Who Are The Major Stakeholders Operating In The Human Immunodeficiency Virus (HIV) Diagnosis Market?

Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Human Immunodeficiency Virus (HIV) Diagnosis Market?

North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp

Browse Through More Reports Similar to the Global Human Immunodeficiency Virus (HIV) Diagnosis Market 2025, By The Business Research Company

Immunohistochemistry Ihc Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Immunohematology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model